Ruka hadi maudhui makuu

Condition · 1 treatment path

Gastrointestinal Stromal Tumour (GIST)

A gastrointestinal stromal tumour (GIST) is a rare sarcoma arising from cells in the wall of the digestive tract, most often the stomach or small bowel. It is typically diagnosed in people over 50.

Severe
Request opinion View roster

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Ilisasishwa mwisho: Jinsi tunavyokusanya na kukagua taarifa

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
1Treatment paths
Specialties
2Specialties
Typical severity
SevereTypical severity

About gastrointestinal stromal tumour (gist)

What to know

Small tumours may cause no symptoms and are found incidentally. Larger ones cause bleeding, anaemia, abdominal pain, a mass or bowel obstruction. Diagnosis uses CT or MRI, endoscopic ultrasound with biopsy, and immunostaining for KIT (CD117) or DOG1, with mutation testing to guide treatment. Risk of recurrence depends on tumour size, site and mitotic rate.

Complete surgical removal is the main treatment for localised GIST. Targeted drugs such as imatinib, a tyrosine kinase inhibitor, are used after surgery for higher-risk tumours, before surgery to shrink large ones, and for advanced disease, usually taken long-term. Regular imaging follows treatment. Because GIST is rare, patients often seek care at specialist sarcoma centres, including abroad.

Pre-flight workup

Tests to have already done

  • Pathology report with tumour site, size, mitotic count and the mutation analysis for KIT and PDGFRA.
  • CT or MRI scans of abdomen and pelvis, and endoscopic ultrasound where the tumour is in the stomach.
  • Operation notes and whether the tumour capsule was intact or ruptured, if surgery has already been done.
  • A record of any imatinib or other targeted therapy, with dose, dates, side effects and response scans.
  • Blood results including blood count and liver function, plus heart assessment if relevant.

Second opinion

When to get a second look

  • Mutation testing has not been done, or the result is unclear, as it decides which drug and dose work.
  • The tumour is large or in a difficult location and you are told it cannot be removed.
  • The tumour is growing on imatinib and next-line drugs are being considered.
  • You are unsure whether to take adjuvant imatinib after surgery and for how long.

Talking to your doctor

Questions to ask

  1. What are the size, mitotic rate and risk category of my tumour?
  2. Which mutation does it carry, and does it respond to imatinib?
  3. Is surgery possible now, or should drug treatment shrink it first?
  4. Do I need adjuvant imatinib after surgery, and for how many years?
  5. How will side effects and response be monitored?
  6. What scans and follow-up will I need?

Outlook

Realistic prognosis

Outlook depends on tumour size, site, mitotic rate and whether it was removed intact. Small low-risk tumours are often cured by surgery, while higher-risk tumours may recur and benefit from imatinib after surgery. Advanced GIST is rarely cured, but imatinib controls disease for years in many patients, with later-line drugs available if it stops working. Treatment is long term and requires regular scans and blood tests.

01 · Specialties

Specialties that treat Gastrointestinal

Specialists Doctors who treat gastrointestinal stromal tumour (gist) Cross-hospital roster across 2+ relevant specialties. View roster

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For gastrointestinal stromal tumour (gist), plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.
  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.
  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.
  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

03 · Treatment paths

Treatment options

All treatments

Where to be treated

Gastrointestinal Stromal Tumour (GIST) treatment by destination

Get a panel match

04 · FAQ

Common questions about gastrointestinal stromal tumour (gist)

Is GIST a type of cancer?

Yes, it is a sarcoma of the digestive tract wall. Its behaviour ranges from low to high risk depending on size, site and mitotic rate.

How long do I take imatinib?

For higher-risk tumours after surgery, imatinib is typically given for three years or longer. In advanced disease, it is continued as long as it works and is tolerated.

Will chemotherapy help?

Standard chemotherapy is not effective for GIST. Targeted drugs like imatinib are the key treatment.

Clinical context

Working up gastrointestinal stromal tumour (gist) properly

A condition like gastrointestinal stromal tumour (gist) is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
Jinsi ukurasa huu ulivyoandaliwa

Mbinu na viwango vya uhariri

This gastrointestinal stromal tumour (gist) overview is written by the editorial team from published Oncology sources and lists 1 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Taarifa za hospitali. Maelezo ya hospitali yanakusanywa kutoka vyanzo vya umma na tovuti za hospitali. Uidhinishaji (JCI, NABH na mengine) huonyeshwa pale tulipo na rekodi. Daima omba hospitali cheti chake cha sasa.
  2. Sifa za madaktari. Sifa, utaalamu na wasifu hutoka wasifu wa daktari hospitalini. Leseni hukaguliwa kwenye rejista ya baraza la kitaifa la madaktari tu pale wasifu unapoonyesha alama ya "Leseni imehakikiwa" yenye tarehe.
  3. Bei. Viwango vya bei ni vya kukadiria, vimekusanywa kutoka orodha za bei na vifurushi vya hospitali na huonyeshwa na tarehe ya mwisho ya kusasishwa. Unacholipa ni kile kilichoandikwa kwenye nukuu ya hospitali.
  4. Maandishi ya kitabibu. Imeandikwa na timu ya wahariri ya Medcasts kutoka vyanzo vya kliniki vilivyochapishwa. Isipokuwa ukurasa umetaja mhakiki kwa jina, haujakaguliwa na daktari.
  5. Uhuru. Hospitali haziwezi kulipa ili kubadilisha nafasi yao kwenye kurasa zetu.
Vyanzo vya taarifa za ukurasa huu
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Gastrointestinal Stromal Tumour (GIST)

Continue evaluating gastrointestinal stromal tumour (gist) care

Condition overview is one entry. These hubs route the same care decision via specialty, surgeon, treatment, and destination — including the doctors actively treating gastrointestinal stromal tumour (gist).

Hatua inayofuata · Gastrointestinal Stromal Tumour (GIST)

Free second opinion on your Gastrointestinal case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.

Pata makadirio ya bei bureMakadirio ya kina kutoka hospitali zilizoidhinishwa, bila malipo Maoni ya pili ya daktari bureMtaalamu anapitia ripoti zako Ongea na mratibuWhatsApp, barua pepe au simu